2 weeks Ago
Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024 BOSTON , Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA , "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2024 , on Tuesday, November 12, 2024 , beginning at 5:30 p.
m. ET . The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.
ginkgobioworks.com , and a replay will be made available. To ask a question ahead of the presentation, please submit them to @ Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected] .
About Ginkgo Bioworks Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.
com and ginkgobiosecurity.com , read our blog , or follow us on social media channels such as X (@ Ginkgo and @ Ginkgo_Biosec ), Instagram (@ GinkgoBioworks ), Threads (@ GinkgoBioworks ) or LinkedIn . Ginkgo Bioworks Contacts: INVESTOR CONTACT: [email protected] MEDIA CONTACT: [email protected] SOURCE Ginkgo Bioworks.
